Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jan 15, 2024; 15(1): 72-80
Published online Jan 15, 2024. doi: 10.4239/wjd.v15.i1.72
Table 1 Comparison of clinical data between positive remodelling group, intermediate remodelling group and negative remodelling group
PR group (n = 31)IR group (n = 8)NR group (n = 55)F/H/χ2 valueP value
Age57.61 ± 12.7756.00 ± 14.9954.35 ± 11.460.7160.491
Sex (%)20 (64.5)5 (62.5)40 (72.7)0.8080.668
Hypertension (%)22 (71)4 (50)37 (67.3)1.2690.530
Diabetes (%)14 (45.2)2 (25)9 (16.4)8.4330.015
Triglyceride1.88 ± 0.971.61 (1.10, 1.67)1.64 (1.09, 2.33)5.0290.081
Cholesterol4.54 (4.16, 5.93)4.80 ± 1.224.14 (3.53, 4.75)3.1590.019
Table 2 Comparison of clinical data between the positive remodelling group and the non positive remodelling group
PR group (n = 31)N-PR group (n = 63)t/z/χ2 valueP value
Age57.61 ± 12.7754.56 ± 11.831.1470.254
Sex (%)20 (64.5)45 (71.4)0.4650.495
Hypertension (%)22 (71)41 (65.1)0.3260.568
Diabetes (%)14 (45.2)11 (17.5)8.1660.004
Triglyceride1.64 (1.23, 2.33)1.55 (1.06, 1.67)2.1910.028
Cholesterol4.54 (4.16, 5.93)4.24 (3.53, 4.89)2.4520.014
Table 3 Analysis of independent factors associated with plaque positive remodelling

OR (95%CI)
P value
Diabetes3.718 (1.207-11.454)0.022
Hypertension1.077 (0.377-3.079)0.890
Sex0.558 (0.189-1.644)0.290
Age0.996 (0.952-1.042)0.860
Triglyceride1.977 (0.979-3.995)0.057